Title:
COMBINATION OF A PARP INHIBITOR AND AN AKT KINASE ACTIVATING COMPOUND
Document Type and Number:
WIPO Patent Application WO/2010/001186
Kind Code:
A4
Abstract:
The primary subject of the invention is the use of a PARP inhibitor and an Akt kinase activating compound in combination in the treatment of pathological conditions related to PARP activation and/or that could benefit from Akt activation. A further subject of the invention is the use of a PARP inhibitor and an Akt kinase activating compound in combination for the preparation of pharmaceutical composition or kit for the treatment of a pathological condition related to PARP activation. The invention also relates to pharmaceutical composition, which contains a PARP-inhibitor and an Akt kinase activating compound together with auxiliaries generally used in pharmacy.
Inventors:
GALLYAS FERENC (HU)
SUEMEGI BALAZS (HU)
VETOE SARA (HU)
ACS PETER (HU)
KOMOLY SAMUEL (HU)
ILLES ZSOLT (HU)
SUEMEGI BALAZS (HU)
VETOE SARA (HU)
ACS PETER (HU)
KOMOLY SAMUEL (HU)
ILLES ZSOLT (HU)
Application Number:
PCT/HU2009/000055
Publication Date:
March 11, 2010
Filing Date:
July 01, 2009
Export Citation:
Assignee:
PECSI TUDOMANYEGYETEM (HU)
GALLYAS FERENC (HU)
SUEMEGI BALAZS (HU)
VETOE SARA (HU)
ACS PETER (HU)
KOMOLY SAMUEL (HU)
ILLES ZSOLT (HU)
GALLYAS FERENC (HU)
SUEMEGI BALAZS (HU)
VETOE SARA (HU)
ACS PETER (HU)
KOMOLY SAMUEL (HU)
ILLES ZSOLT (HU)
International Classes:
A61K45/06
Attorney, Agent or Firm:
DANUBIA PATENT AND LAW OFFICE LLC (Budapest, HU)
Download PDF:
Previous Patent: THIENO [2,3-B] PYRIDINE COMPOUNDS WITH MGLUR ACTIVITY
Next Patent: CIRCUIT TO PROVIDE TESTABILITY TO A SELF-TIMED CIRCUIT
Next Patent: CIRCUIT TO PROVIDE TESTABILITY TO A SELF-TIMED CIRCUIT